| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cancer and inflammation: promise for biologic therapy. | J Immunother | 2010 | 1.72 |
| 2 | Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients. | J Immunother | 2008 | 1.32 |
| 3 | PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccines. | Cancer Res | 2013 | 1.22 |
| 4 | CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. | J Immunol | 2002 | 1.09 |
| 5 | Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. | J Virol | 2002 | 1.06 |
| 6 | Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. | Clin Vaccine Immunol | 2009 | 0.77 |